A
FULC icon

AlphaQuest’s Fulcrum Therapeutics FULC Stock Holding History

AlphaQuest’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,658
Closed -$109K – 788
2025
Q4 		$109K Sell
9,658
-25,717
-73% -$262K 0.01% 1710
2025
Q3 		$325K Buy
+35,375
New +$256K 0.02% 1104
2024
Q4 		– Sell
-4,392
Closed -$15.7K – 1809
2024
Q3 		$15.7K Sell
4,392
-21,772
-83% -$162K ﹤0.01% 1524
2024
Q2 		$162K Buy
+26,164
New +$198K 0.02% 812

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

AlphaQuest's FULC Position: Q1 2026 in Review

AlphaQuest sold out of Fulcrum Therapeutics (FULC) in Q1 2026, closing a stake of 9,658 shares — an estimated $109K sold.

AlphaQuest first reported a position in FULC in Q2 2024 and held it in 4 quarters. The position peaked at $325K in Q3 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • AlphaQuest reported no remaining Fulcrum Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 9,658 Fulcrum Therapeutics shares in Q1 2026, an estimated $109K.
  • AlphaQuest first reported a position in Fulcrum Therapeutics in Q2 2024 and held it in 4 quarters.
  • AlphaQuest's Fulcrum Therapeutics position peaked at $325K in Q3 2025.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.